scholarly article | Q13442814 |
P50 | author | Neil S Lagali | Q46067676 |
Lasse D Jensen | Q50532645 | ||
Pierfrancesco Mirabelli | Q55834734 | ||
Anthony Mukwaya | Q58403794 | ||
Anton Lennikov | Q60327571 | ||
Muthukumar Thangavelu | Q87506577 | ||
Mieszko Lachota | Q87792754 | ||
Mira Schaupper | Q89867185 | ||
Zaheer Ali | Q89867187 | ||
P2093 | author name string | Zaheer Ali | |
Mira Schaupper | |||
Anton Lennikov | |||
Muthukumar Thangavelu | |||
Mieszko Lachota | |||
P2860 | cites work | Regulation of hypoxia-inducible factor-1alpha by NF-kappaB | Q24657260 |
NF-κB, the first quarter-century: remarkable progress and outstanding questions | Q26822516 | ||
Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin) | Q26823757 | ||
Systemic side effects of eye drops: a pharmacokinetic perspective | Q28066720 | ||
Clinical correlates of common corneal neovascular diseases: a literature review | Q28257676 | ||
The endothelial-cell-derived secreted factor Egfl7 regulates vascular tube formation | Q28590677 | ||
Vascular endothelial growth factor (VEGF)-driven actin-based motility is mediated by VEGFR2 and requires concerted activation of stress-activated protein kinase 2 (SAPK2/p38) and geldanamycin-sensitive phosphorylation of focal adhesion kinase | Q28646403 | ||
NF-kappaB: a key role in inflammatory diseases | Q29617726 | ||
In vivo imaging of embryonic vascular development using transgenic zebrafish | Q29619921 | ||
IKKβ regulates essential functions of the vascular endothelium through kinase-dependent and -independent pathways | Q30501022 | ||
Corneal neovascularization | Q30707020 | ||
Factors regulating capillary remodeling in a reversible model of inflammatory corneal angiogenesis | Q30804219 | ||
The IKK complex, a central regulator of NF-kappaB activation | Q33693802 | ||
CXCL5 is required for angiogenesis, but not structural adaptation after small bowel resection | Q33708424 | ||
Impacts of hypoxia-inducible factor-1 knockout in the retinal pigment epithelium on choroidal neovascularization | Q33960351 | ||
IKK/NF-kappaB signaling: balancing life and death--a new approach to cancer therapy | Q34048503 | ||
The nuclear factor NF-kappaB pathway in inflammation | Q34114512 | ||
HIF-1α Promotes A Hypoxia-Independent Cell Migration | Q34157978 | ||
The chemokine receptor CXCR2 ligand KC (CXCL1) mediates neutrophil recruitment and is critical for development of experimental Lyme arthritis and carditis. | Q34290822 | ||
Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial | Q34501650 | ||
Corneal neovascularization: an anti-VEGF therapy review | Q34641522 | ||
Inflammation, but not hypoxia, mediated HIF-1alpha activation depends on COX-2 | Q34683465 | ||
NF-κB in the liver--linking injury, fibrosis and hepatocellular carcinoma | Q35808323 | ||
Tumor-suppressive microRNA-497 targets IKKβ to regulate NF-κB signaling pathway in human prostate cancer cells | Q35835265 | ||
Inhibition of VEGF expression and corneal neovascularization by shRNA targeting HIF-1α in a mouse model of closed eye contact lens wear | Q35891550 | ||
VEGF-B-Neuropilin-1 signaling is spatiotemporally indispensable for vascular and neuronal development in zebrafish. | Q36268590 | ||
Sex-specific regulation of chemokine Cxcl5/6 controls neutrophil recruitment and tissue injury in acute inflammatory states | Q36324954 | ||
Hypoxia-induced neutrophil survival is mediated by HIF-1alpha-dependent NF-kappaB activity | Q36402484 | ||
Inhibitors of NF-kappaB signaling: 785 and counting | Q36637918 | ||
NF-kappa B: a new player in angiostatic therapy | Q37088045 | ||
Differences in cardiovascular toxicities associated with cigarette smoking and snuff use revealed using novel zebrafish models | Q37120314 | ||
NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha | Q37158836 | ||
A role for NF-kappaB-dependent gene transactivation in sunburn. | Q37202396 | ||
Intrastromal Injection of Bevacizumab in the Management of Corneal Neovascularization: About 25 Eyes | Q37218666 | ||
Topical bevacizumab in the treatment of corneal neovascularization: results of a prospective, open-label, noncomparative study. | Q37244781 | ||
The NF-kappaB family of transcription factors and its regulation | Q37672294 | ||
Anti-VEGF Treatment of Corneal Neovascularization. | Q37949024 | ||
Anti-VEGF therapy with bevacizumab for anterior segment eye disease. | Q37967000 | ||
Carotenoids, inflammation, and oxidative stress--implications of cellular signaling pathways and relation to chronic disease prevention | Q38240969 | ||
A microarray whole-genome gene expression dataset in a rat model of inflammatory corneal angiogenesis | Q38375654 | ||
IKKβ Regulates VEGF Expression and Is a Potential Therapeutic Target for Ovarian Cancer as an Antiangiogenic Treatment | Q38914723 | ||
Freeze-gelled silk fibroin protein scaffolds for potential applications in soft tissue engineering | Q39545208 | ||
Inhibition of IkappaB kinase beta restrains oncogenic proliferation of pancreatic cancer cells | Q40008003 | ||
A novel NF-kappaB inhibitor, IMD-0354, suppresses neoplastic proliferation of human mast cells with constitutively activated c-kit receptors | Q40488484 | ||
Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide | Q40910373 | ||
Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice | Q40956523 | ||
Ikk2 regulates cytokinesis during vertebrate development | Q41387328 | ||
Genome-wide expression differences in anti-Vegf and dexamethasone treatment of inflammatory angiogenesis in the rat cornea. | Q41423380 | ||
Amelioration of endotoxin-induced uveitis treated with an IκB kinase β inhibitor in rats. | Q42400395 | ||
Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-kappaB signal pathways. | Q42500751 | ||
NF-kappaB plays a key role in hypoxia-inducible factor-1-regulated erythropoietin gene expression | Q44249433 | ||
Zebrafish: a preclinical model for drug screening | Q44847979 | ||
Inhibition of IkappaB phosphorylation in cardiomyocytes attenuates myocardial ischemia/reperfusion injury | Q44934421 | ||
Effect of double-stranded RNA on the expression of epithelial neutrophil activating peptide-78/CXCL-5 in human endothelial cells | Q45239892 | ||
Antiallergic and anti-inflammatory effects of a novel I kappaB kinase beta inhibitor, IMD-0354, in a mouse model of allergic inflammation | Q46320157 | ||
Ten years of anti-vascular endothelial growth factor therapy | Q46407140 | ||
A novel IkappaB kinase-beta inhibitor ameliorates bleomycin-induced pulmonary fibrosis in mice | Q46925948 | ||
Opposing effects of circadian clock genes bmal1 and period2 in regulation of VEGF-dependent angiogenesis in developing zebrafish | Q47073350 | ||
IκB kinase-β inhibitor IMD-0354 beneficially suppresses retinal vascular permeability in streptozotocin-induced diabetic mice. | Q51055452 | ||
Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. | Q52886344 | ||
Time-lapse in vivo imaging of corneal angiogenesis: the role of inflammatory cells in capillary sprouting. | Q53243786 | ||
Regulation of endothelial cell migration by amphiphiles - are changes in cell membrane physical properties involved? | Q53579619 | ||
Use of the mouse aortic ring assay to study angiogenesis | Q58313759 | ||
CCL2 Shapes Macrophage Polarization by GM-CSF and M-CSF: Identification of CCL2/CCR2-Dependent Gene Expression Profile | Q61865899 | ||
VEGF expression in human macrophages is NF-kappaB-dependent: studies using adenoviruses expressing the endogenous NF-kappaB inhibitor IkappaBalpha and a kinase-defective form of the IkappaB kinase 2 | Q64378091 | ||
Neutrophils promote inflammatory angiogenesis via release of preformed VEGF in an in vivo corneal model | Q82251889 | ||
Sphingosylphosphorylcholine stimulates CCL2 production from human umbilical vein endothelial cells | Q83516314 | ||
Cellular level characterization of capillary regression in inflammatory angiogenesis using an in vivo corneal model | Q84535269 | ||
An IκB kinase 2 inhibitor IMD-0354 suppresses the survival of adult T-cell leukemia cells | Q84997618 | ||
Early effects of dexamethasone and anti-VEGF therapy in an inflammatory corneal neovascularization model | Q88089018 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 2 | |
P921 | main subject | NF-κB | Q411114 |
P304 | page(s) | 267-285 | |
P577 | publication date | 2018-01-13 | |
P1433 | published in | Angiogenesis | Q15753544 |
P1476 | title | Selective IKK2 inhibitor IMD0354 disrupts NF-κB signaling to suppress corneal inflammation and angiogenesis | |
P478 | volume | 21 |
Q89124983 | Current and emerging therapies for corneal neovascularization |
Q96348268 | Inhibition of miR-450b-5p ameliorates hepatic ischemia/reperfusion injury via targeting CRYAB |
Q92308065 | Mesenchymal Stem Cell-Derived Extracellular Vesicles for Corneal Wound Repair |
Q89551530 | Pharmacological Inhibition of Caspase-8 Suppresses Inflammation-Induced Angiogenesis in the Cornea |
Q101138707 | Synergistic interactions of PlGF and VEGF contribute to blood-retinal barrier breakdown through canonical NFκB activation |
Q49991844 | Time-dependent LXR/RXR pathway modulation characterizes capillary remodeling in inflammatory corneal neovascularization. |
Search more.